COLL vs L · P/E 17, rev $181.9M vs P/E 14, rev $18.45B
Collegium Pharmaceutical Inc (COLL) versus Loews Corp (L) — a side-by-side from cached financials, not a winner call.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Loews Corp (L) is a insurance - property & casualty company listed on NYSE.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Latest reported L revenue for 2025-12-31 was $18.45B. Net income was $1.67B. Revenue was up 5.4% from 2024-12-31 to 2025-12-31. L currently screens at market cap $22.36B and trailing P/E 13.8.
COLL currently screens at market cap $1.12B and trailing P/E 16.8. L currently screens at market cap $22.36B and trailing P/E 13.8.
Not investment advice. Open the COLL and L stock pages for the full models.
Not investment advice.